Search
for
Sort by
Research 30 of 1000+
- Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study
- Cardiovascular risk factors and events in women with androgen excess
- Alopecia and cardiovascular events
- 42276 Long-Term Safety of Ixekizumab Treatment in Adult Patients with Psoriasis, Psoriatic Arthritis, or Axial Spondyloarthritis: A Post-hoc Analysis of End-Of-Study Program Data Relating to Major Adverse Cardiovascular Events
- Anabolic androgenic steroids impact on cardiovascular risk and cardiovascular events. The literature review
- Association between androgenetic alopecia and risk of cardiovascular events in young males: a systematic review and meta-analysis
- SAT-279 The Effect of Chronic 5-alpha Reductase Inhibition on Clinically Apparent and Silent Cardiovascular Events
- Incidence Rates of Infections, Malignancies, Thromboembolism, and Cardiovascular Events in an Alopecia Areata Cohort from a US Claims Database
- What does the research say about androgen use and cerebrovascular events?
- Response to “The Role of Patient‐ and Drug‐Related Factors in Oral Minoxidil and Pericardial Effusion: Analyses of Data From the United States Food and Drug Administration Adverse Event Reporting System”
- Cardiovascular Safety Signals of Oral Versus Topical Minoxidil in FAERS: A Disproportionality Analysis (Analytic Cohort 2012–2025)
- Hidradenitis suppurativa and major adverse cardiac events: A systematic review and meta-analysis
- Characterization and Management of Adverse Events of Low-Dose Oral Minoxidil Treatment for Alopecia: A Narrative Review
- Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
- Polycystic ovary syndrome
- Effect of estrogens on skin aging and the potential role of SERMs
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome
- The Frequency of Metabolic Syndrome is Higher Among PCOS Brazilian Women With Menstrual Irregularity Plus Hyperandrogenism
- Polycystic Ovary Syndrome: Special Diagnostic and Therapeutic Considerations for Children
- Severe androgenetic alopecia as a proxy of metabolic syndrome in male psoriatic patients older than 59 years
- JAK Inhibitor Safety in Atopic Dermatitis and Alopecia Areata: A 4.5-Year Real-World Retrospective Cohort Study
- Expanding the therapeutic landscape of minoxidil for androgenetic alopecia: topical, oral and sublingual formulations
- ADVERSE EFFECTS OF RITLECITINIB IN ADULTS AND ADOLESCENTS WITH ALOPECIA AREATA: A LITERATURE REVIEW
- A Retrospective Study on the Safety of Systemic Minoxidil for Hair Loss in the Older Population
- Effects Of Hormone Therapy On The Laboratory Profile Of Transgender People: A Scoping Review
- Highlights
- 5α-Reductase inhibitor therapy: Should physicians be concerned with persistent diminished libido, erectile dysfunction and depression in a subset of patients?
- Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome